myriad genetics glp-1 receptor agonist weight management diabetes treatments New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within Agonists Advances in GLP-1 receptor agonists
Description
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide-derived analogs that were initially investigated to treat type 2 diabetes
The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.
FDA updates rules on compounded GLP-1 drugs, impacting patients and providers
- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake
Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health
Meanwhile, orforglipron demonstrated significant weight loss efficacy [8] consistent with injectable GLP-1 medicines
